ClinicalTrials.Veeva

Menu

Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

S

Sharp HealthCare

Status

Completed

Conditions

Intraventricular Haemorrhage Neonatal
Death; Neonatal

Treatments

Procedure: Umbilical cord milking UCM
Procedure: Delayed cord clamping DCC

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03019367
PREMOD2
1R01HD088646-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study is being done to find out whether umbilical cord milking (UCM) is at least as good as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent death in premature newborns. The investigators will study short and long term outcomes of infants delivered before 32 weeks gestation that receive either UCM or DCC.

* The trial was stopped by the DSMB for safety in the small strata. They subsequently allowed for continuation of the trial in infants 29-32+6 wk GA.

Full description

Aim 1. Compare the incidence of severe intraventricular hemorrhage (IVH) and/or death in premature newborns <33 weeks gestational age (GA) delivered by C/S receiving UCM to those receiving DCC.

Hypothesis1: First demonstrate infants in the UCM group are not inferior to the DCC group (reject H10).

Hypothesis2: If H1 is true, demonstrate lower incidence of severe IVH and/or death in UCM infants compared to DCC.

Aim 2. Compare the safety and efficacy profiles of premature newborns <33 weeks GA delivered by C/S receiving UCM vs. DCC during their hospitalization.

Hypothesis3: UCM group will have a decreased need for resuscitation interventions with no differences in bilirubin or polycythemia compared to DCC.

Hypothesis4: UCM group will have improved blood pressures in the first 24 hours of life compared to DCC.

Aim 3 (exploratory). To compare the outcomes of premature newborns <33 weeks GA delivered by C/S (Cesarean section) (from Aims 1 and 2) with those born by V/D (vaginal delivery) receiving UCM or DCC.

Enrollment

1,201 patients

Sex

All

Ages

23 to 33 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 23 to 32 +6 Gestational age (currently enrolling 29 to 32+6 weeks)
  • Multiples without Twin-to-twin Transfusion Syndrome (TTTS)

Exclusion criteria

  • Congenital anomalies
  • Major cardiac defects
  • Placental abruption or previa with hemorrhage
  • Cord prolapse
  • Hydrops
  • Bleeding Accreta
  • Monochorionic multiples with evidence of TTTS
  • Fetal or maternal risk (i.e. compromise)
  • Parents declined study
  • Unlikely to return for 2 yr Follow Up

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

1,201 participants in 2 patient groups

Umbilical cord milking UCM
Active Comparator group
Description:
Milking the umbilical cord 4 times towards the infant at a speed of 20cm/2seconds.
Treatment:
Procedure: Umbilical cord milking UCM
Delayed cord clamping DCC
Active Comparator group
Description:
Delayed clamping of the umbilical cord for at least 60 seconds.
Treatment:
Procedure: Delayed cord clamping DCC

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems